Senseonics Scrounges Up $20 Million To Advance Continuous Glucose Monitoring Implant

There are just a handful of big medical device companies that dominate the continuous glucose monitoring space and Senseonics is looking to compete with them. It has raised $20 million across two tranches from current investors to advance an implant to continuously monitor blood-glucose levels. It transmits that data to patients and doctors through a smartphone app. Although the Germantown, Maryland company has been around for 17 years, it spent most of that time focused on research.

Help employers find you! Check out all the jobs and post your resume.